Dr. Sheldon Jay Freedman, MD

Dr. Freedman practices at Freedman Urology in Las Vegas, Nevada.

Dr. Freedman's NPI, 1659483444, was assigned on August 31, 2006. Dr. Freedman graduated from Jefferson Medical College of Thomas Jefferson University in 1977. Dr. Freedman holds Nevada license 4828.

Dr. Freedman's primary practice is Freedman Urology, at 653 N Town Center Dr Ste 308, Las Vegas, NV 89144-0517. The practice phone is (702) 732-0282.

Dr. Freedman's primary practice is Freedman Urology in Las Vegas, Nevada. Dr. Freedman is also affiliated with Summerlin Hospital Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Freedman practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Freedman's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Freedman is licensed in Nevada.

CMS data shows 6,136 Medicare services from Dr. Freedman across 22 procedure codes in 2024, for 789 Medicare patients. Medicare paid $330,898 for them.

CMS counts 789 Medicare patients who saw Dr. Freedman in 2024. The largest group is 75 to 84, with 362 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 1% are also on Medicaid. Their average risk score is 1.02, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Freedman's median patient age at 68, with 12% women.

In 2024, Dr. Freedman wrote 1,585 Medicare Part D claims for 462 patients. 90% of them were for generic drugs. CMS names the drug for 1,471 of them, across 23 drugs with 11 or more claims each, at $166,637 in total drug cost. In 2023, CMS named 1,537 claims across 24 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Freedman for performance year 2024, reported individually. Dr. Freedman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 17 procedures of prostate resection by Dr. Freedman, more than 76% of the clinicians it reports for that procedure.

Dmand AI links 13 papers to Dr. Freedman, published from 2012 to 2023. 2018 was the busiest year, with 2. The most frequent topics are Prostatic Hyperplasia, Lower Urinary Tract Symptoms and Prostate. Dr. Freedman has published most often in J Urol. Dr. Freedman's most frequent co-authors are Barrett E. Cowan, MD, Jed C. Kaminetsky, MD and Claus G. Roehrborn, MD.

Dmand AI links Dr. Freedman to 3 clinical trials. 2 are still active or recruiting. Conditions studied include Color Vision Defects, Prostatic Neoplasms and Urinary Incontinence, Stress.

CMS Open Payments shows 496 general payments to Dr. Freedman from 58 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 51% of the total. Bioness Inc paid the most, $5,000. It also lists 5 research payments totaling $23,112 from 2016 to 2019.

Dr. Freedman graduated from Jefferson Medical College of Thomas Jefferson University in 1977.